209 related articles for article (PubMed ID: 17159717)
1. [Classification criteria of scleroderma].
Cabane J;
Presse Med; 2006 Dec; 35(12 Pt 2):1916-22. PubMed ID: 17159717
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.
Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y;
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):68-75. PubMed ID: 30277860
[TBL] [Abstract][Full Text] [Related]
3. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry.
Delisle VC; Hudson M; Baron M; Thombs BD; And The Canadian Scleroderma Research Group A
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-10-4. PubMed ID: 24144459
[TBL] [Abstract][Full Text] [Related]
4. Pilot study to determine whether transient receptor potential melastatin type 8 (TRPM8) antibodies are detected in scleroderma.
Shah AA; Montagne J; Oh SY; Wigley FM; Casciola-Rosen L
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S123-6. PubMed ID: 26242276
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
[TBL] [Abstract][Full Text] [Related]
6. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
[TBL] [Abstract][Full Text] [Related]
7. Classification of systemic sclerosis. Visions and reality.
Wollheim FA
Rheumatology (Oxford); 2005 Oct; 44(10):1212-6. PubMed ID: 15870151
[TBL] [Abstract][Full Text] [Related]
8. [Contemporaneous clinical picture of systemic sclerosis].
Wiesik-Szewczyk E; Olesińska M
Pol Merkur Lekarski; 2010 May; 28(167):416-20. PubMed ID: 20568410
[TBL] [Abstract][Full Text] [Related]
9. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
10. Time to diagnosis in systemic sclerosis: is sex a factor?
Hudson M; Thombs B; Baron M;
Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
[TBL] [Abstract][Full Text] [Related]
11. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis in Sarawak: a profile of patients treated in the Sarawak General Hospital.
Teh CL; Kuan YC; Wong JS
Rheumatol Int; 2009 Aug; 29(10):1243-5. PubMed ID: 19373465
[TBL] [Abstract][Full Text] [Related]
13. [Systemic sclerosis - diagnosis and classification].
Genth E; Krieg T
Z Rheumatol; 2006 Jul; 65(4):268-74. PubMed ID: 16804700
[TBL] [Abstract][Full Text] [Related]
14. Diffuse scleroderma and Raynaud's disease.
JABLONSKA S; BUBNOW B; SZCZEPANSKI A
Br J Dermatol; 1962 May; 74():174-82. PubMed ID: 14450537
[No Abstract] [Full Text] [Related]
15. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis.
Ng SC
Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
[TBL] [Abstract][Full Text] [Related]
17. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
Arthritis Rheum; 1980 May; 23(5):581-90. PubMed ID: 7378088
[TBL] [Abstract][Full Text] [Related]
18. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis.
Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S
Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644
[TBL] [Abstract][Full Text] [Related]
19. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
20. [Systemic sclerosis--clinical course and treatment possibilities].
Szymańska E; Maj M; Rudnicka L
Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]